Amanda Reynolds

Amanda Reynolds is an experienced professional in the field of pharmacovigilance, currently serving as Senior Director at PTC Therapeutics, Inc. since July 2018. Prior roles include Director at PTC Therapeutics, Director and Cross-Sector Country Safety Team Lead at Johnson & Johnson, and several positions at Shire, where responsibilities encompassed safety analytics, benefit-risk assessment, and interim deputy EU QPPV. Amanda began a career in pharmacovigilance at Wyeth Pharmaceuticals as a Pharmacovigilance Scientist, progressing to Senior Pharmacovigilance Scientist, before holding managerial roles. Amanda holds a BSc in Biology from the University of Bath, obtained from 2003 to 2006.